Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19860
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZiemssen, T.-
dc.contributor.authorHobart, J.-
dc.contributor.authorFEYS, Peter-
dc.contributor.authorLinnebank, M.-
dc.contributor.authorGoodman, A.-
dc.contributor.authorMcNeill, M.-
dc.contributor.authorZhong, J.-
dc.contributor.authorMehta, L.-
dc.date.accessioned2015-11-30T15:12:53Z-
dc.date.available2015-11-30T15:12:53Z-
dc.date.issued2015-
dc.identifier.citationEUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621-
dc.identifier.issn1351-5101-
dc.identifier.urihttp://hdl.handle.net/1942/19860-
dc.language.isoen-
dc.publisherWILEY-BLACKWELL-
dc.rights© 2015 European Journal of Neurology-
dc.titleLong-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateJUN, 2015-
local.bibliographicCitation.conferencename1st Congress of the European-Academy-of-Neurology-
local.bibliographicCitation.conferenceplaceBerlin, GERMANY-
dc.identifier.epage621-
dc.identifier.issueS1-
dc.identifier.spage621-
dc.identifier.volume22-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notes[Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Hobart, J.] Univ Plymouth, Peninsula Sch Med, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Hobart, J.] Univ Plymouth, Peninsula Sch Dent, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Feys, P.] Univ Hasselt, Diepenbeek, Belgium. [Linnebank, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland. [Goodman, A.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA. [McNeill, M.] Biogen Idec Inc, Maidenhead, Berks, England. [Zhong, J.; Mehta, L.] Biogen Idec Inc, Cambridge, MA USA.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000364239000254-
item.fulltextWith Fulltext-
item.contributorZiemssen, T.-
item.contributorHobart, J.-
item.contributorFEYS, Peter-
item.contributorLinnebank, M.-
item.contributorGoodman, A.-
item.contributorMcNeill, M.-
item.contributorZhong, J.-
item.contributorMehta, L.-
item.fullcitationZiemssen, T.; Hobart, J.; FEYS, Peter; Linnebank, M.; Goodman, A.; McNeill, M.; Zhong, J. & Mehta, L. (2015) Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study. In: EUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621.-
item.accessRightsRestricted Access-
crisitem.journal.issn1351-5101-
crisitem.journal.eissn1468-1331-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
selection (34).pdf
  Restricted Access		194.07 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.